Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)

Completed · Phase 2/Phase 3 · Has a placebo group

Conditions studied: Nocturia

In brief

This study will investigate the efficacy and safety of fedovapagon in the treatment of nocturia in men with BPH.

Key facts

Study ID
NCT02637960
Run by
Vantia Ltd
People needed
432
Starts
2016-03-01
Expected to finish
2017-08-01
Last updated by the study team
2018-10-31

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.